Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 80
Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic Targets
F. Javier Luque, Diego Muñoz‐Torrero
Accounts of Chemical Research (2024)
Open Access | Times Cited: 18
New insights in animal models of neurotoxicity-induced neurodegeneration
Coral Sanfeliu, Clara Bartra, Cristina Suñol, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 17
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 45
Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer’s Disease: Experimental and Computational Insights
Nicolás Puentes‐Díaz, Diego Chaparro, David Morales‐Morales, et al.
ACS Omega (2023) Vol. 8, Iss. 5, pp. 4508-4526
Open Access | Times Cited: 36
Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling
Hyunju Lee, Hyang‐Sook Hoe
Pharmacological Research (2023) Vol. 190, pp. 106725-106725
Open Access | Times Cited: 24
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults
Francesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116353-116353
Open Access | Times Cited: 10
Artificial Intelligence for Cancer Detection—A Bibliometric Analysis and Avenues for Future Research
Erik Karger, Marko Kureljusic
Current Oncology (2023) Vol. 30, Iss. 2, pp. 1626-1647
Open Access | Times Cited: 21
Three to Tango: Inhibitory Effect of Quercetin and Apigenin on Acetylcholinesterase, Amyloid-β Aggregation and Acetylcholinesterase-Amyloid Interaction
Irene Álvarez-Berbel, Alba Espargaró, Antonio Viayna, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2342-2342
Open Access | Times Cited: 19
Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease
Ana Matošević, Dejan Opsenica, Marta Spasić, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110620-110620
Closed Access | Times Cited: 11
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and Their Pharmacological Implication: A Medicinal Chemistry-Oriented Perspective Outline
Vikas Rana, Shayantan Ghosh, Akanksha Bhatt, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 29, pp. 4725-4744
Closed Access | Times Cited: 4
DHPMs C5 Amide Bearing Benzothiazole Moiety Inhibit AChE: Design, Synthesis, In Vitro and In Silico Studies
Pardis Samiei, Dara Dastan, Ahmad Ebadi
Russian Journal of Bioorganic Chemistry (2025) Vol. 51, Iss. 1, pp. 340-353
Closed Access
Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
Erik Karger, Marko Kureljusic
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1492-1492
Open Access | Times Cited: 15
Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases
David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8312-8312
Open Access | Times Cited: 7
Abelmoschus eculentus Seed Extract Exhibits In Vitro and In Vivo Anti-Alzheimer’s Potential Supported by Metabolomic and Computational Investigation
Hussain T. Bakhsh, Fatma Alzahraa Mokhtar, Abeer H. Elmaidomy, et al.
Plants (2023) Vol. 12, Iss. 12, pp. 2382-2382
Open Access | Times Cited: 7
A Bibliometric and Visual Analysis of Exercise Intervention Publications for Alzheimer’s Disease (1998–2021)
Xiao-Wei Feng, Maryam Hadizadeh, Lin-Hong Zheng, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5903-5903
Open Access | Times Cited: 12
Selecting Multitarget Peptides for Alzheimer’s Disease
Anne Kasus‐Jacobi, Jennifer L. Washburn, Riley B. Laurence, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1386-1386
Open Access | Times Cited: 9
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases
Mihaela-Liliana Ţînţaş, Ludovic Peauger, Anaïs Barré, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 963-980
Open Access | Times Cited: 1
Inflammatory role of S100A8/A9 in the central nervous system non-neoplastic diseases
Qi Tian, Zhijie Li, Ziang Yan, et al.
Brain Research Bulletin (2024) Vol. 218, pp. 111100-111100
Open Access | Times Cited: 1
In Silico and In Vitro Studies of Benzothiazole-Isothioureas Derivatives as a Multitarget Compound for Alzheimer’s Disease
Martha Cecilia Rosales‐Hernandéz, Leticia Guadalupe Fragoso Morales, José Correa‐Basurto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12945-12945
Open Access | Times Cited: 7
Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?
Kinga Czarnota-Łydka, Katarzyna Kucwaj‐Brysz, Patryk Pyka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8768-8768
Open Access | Times Cited: 5
A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer’s Disease Mice Models
Júlia Jarné‐Ferrer, Christian Griñán‐Ferré, Aina Bellver‐Sanchís, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 908-908
Open Access | Times Cited: 4
Design, Synthesis and Biological Evaluation of New Thiosemicarbazone-Acridine Derivatives as Multi-Target-Directed Ligand (Mtdl) for Alzheimer's Disease
Gleyton Leonel Silva Sousa, Nathália Fonseca Nadur, Larissa A. Ferreira, et al.
(2024)
Closed Access
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties
Caterina Pont, Anna Sampietro, F. Javier Pérez-Areales, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 982-982
Open Access
Page 1 - Next Page

Scroll to top